Shivani Chawla

Shivani Chawla

Auto-generated profile, based on publicly available information

Shivani Chawla

Shri Baba Mastnath Institute of Pharmaceutical Sciences and Research, Baba Mastnath University, Rohtak, Haryana, 124001, India

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2023 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
SCShivani Chawla
Shivani Chawla
SSShweta Sharma
Shweta Sharma
SKSarfraj Kashid
Sarfraj Kashid
PVPRABHAKAR VERMA
PRABHAKAR VERMA
ASAshu Sapra
Ashu Sapra
A rising number of researchers are interested in thiophene-based analogs as they have wide possibilities of biological potential in the largely developing chemical world of the heterocyclic moiety. It also occupies a central position in synthetic organic chemistry and is of the highest theoretical and practical importance. It became an important moiety for researchers to discover combinatorial libraries and implement the efforts in search of the lead entity. Moreover, it helps medicinal chemists to improve sophisticated molecules with a broad range of pharmacological activities. Thiophene and its synthetic derivatives are a prominent heterocyclic compound class with intriguing uses in medical chemistry. It has been manifesting to be an effective drug in current respective diseases scenario. It has been discovered that thiophene had an extensive spectrum of pharmacological potential with numerous applications in academic interest, in the pharmaceutical industry, material science, and medicinal chemistry. Antimitotic, antimicrobial, anti-inflammatory, anticonvulsant, antipsychotic, antiarrhythmic, anti-anxiety, antifungal, antioxidant, estrogen receptor regulating, and anti-cancer are one of the pharmacological and physiological activities of thiophene moiety. However, there are some marketed formulations available such as Thiophenfurin, Teniposide, Cefoxitin, Ticaconazole, Sertaconazole, Suprofen, ketotifen, Brinzolamide, Dorzolamide, Tiotropium which contain thiophene nucleus. Thus, in brief, gathering recent data is necessary to comprehend the present scenario of thiophene moiety for scientific research purposes and highlights a broad view of the biological potential of compounds having a thiophene nucleus.

3 October 2025 in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
SCShivani Chawla
Shivani Chawla
RGRishikesh Gupta
Rishikesh Gupta
SJSudhanshu Kumar Jha
Sudhanshu Kumar Jha
SSShamim Shamim
Shamim Shamim
SKSarfraj Kashid
Sarfraj Kashid
KJKeshav Taruneshwar Jha
Keshav Taruneshwar Jha
Stereoisomerism in addition to conformational, geometrical, and optical isomerism, has considerable effects on the stability, reactivity, and functioning of molecules. Therefore, the objective of this article is to review the recent developments and research on stereoisomerism, including its consequences in various branches of science. The energetics and stability of conformational isomerism, which depict the concept of cis-trans and E/Z configurations of geometric isomerism, elucidate the molecular behavior and the efficacy of drugs, also discussed. The consequence of stereochemistry on pharmacology and drug design is elucidated by optical isomerism in terms of chirality and enantiomorphic effects. To exemplify the use of stereoisomerism in drug development, this review, offers wide case studies of NSAIDs, anticancer drugs, and antibiotic drugs. In this Article, the phenomenon of stereoisomerism is also primarily discussed concerning biomolecules such as proteins, carbohydrates, lipids, and nucleic acids. Recent advances in comparison operations include computer-aided drug design, advances in personalized medicine, and new therapies such as DNA and peptide drugs, including their possible impacts on the business and natural world. The primary aim of the review is to thoroughly investigate and examine stereoisomerism and its wide-ranging implications.

18 March 2026 in Current Bioactive Compounds
Verified
Journal Article
Closed access
PDF file
KAKaushal Arora
Kaushal Arora
JGJugnu Goyal
Jugnu Goyal
MCMehak Chugh
Mehak Chugh
DSDeepanshu Sindhwani
Deepanshu Sindhwani
SCShivani Chawla
Shivani Chawla
PVPRABHAKAR VERMA
PRABHAKAR VERMA
Background: Thymol, a natural monoterpenoid compound found in thyme species, acts as a promising molecule for drug development. Linking thymol with aryl amines via azo coupling markedly improves its therapeutic property, resulting in the creation of multipurpose agents that have strong antimicrobial, antioxidant, and anticancer activities. Objective: In this present study, a new series of thymol-based azo-derivatives was synthesized and assessed for in vitro antimicrobial, antioxidant, and anticancer activity. Methodology: In this study, a series of thymol-azo-aryl derivatives were synthesized, and various techniques, such as FTIR, NMR (1H and 13C), MS, and elemental analysis, were used to confirm their structure. After synthesizing the new compounds, they were tested for in vitro biological activities. This included testing their antimicrobial potential by using the tube dilution assay and measuring their antioxidant capacity by the DPPH method. Finally, we explored their therapeutic potential by assessing their inhibitory effects on A-549 cancer cell growth through MTT assays. Result: Among the tested compounds, H2 really stood out with its broad-spectrum antimicrobial punch, hitting MIC values as low as 0.04 μg/mL against E. faecalis, 0.06 μg/mL for S. aureus, 0.07 μg/mL versus P. aeruginosa, and 0.06 μg/mL against E. coli. Additionally, H2 also demonstrated the most potent antifungal activity, achieving MIC values of 0.04 μg/mL against C. albicans and 0.05 μg/mL against A. niger. In terms of antioxidant capacity, H14 was the most effective, yielding an IC50 = 9.70 μg/mL value, which actually surpasses the standard antioxidant, ascorbic acid. H21 exhibited significant anticancer efficacy (IC50 = 286.57 nM), surpassing doxorubicin. Discussion: This study demonstrated that the incorporation of the azo group into the thymol moiety substantially enhances its biological profile. Notably, derivatives H2, H14, and H21 exhibited significant antimicrobial, antioxidant, and anticancer effects, underscoring the therapeutic potential of these modifications for novel drug development. Conclusion: The newly synthesized thymol azo derivatives exhibited potent antimicrobial, antioxidant, and anticancer properties. Mainly, H2, H14, and H21 showed the best biological activity. These findings suggest that these compounds could serve as potential lead structures for future drug discovery and development efforts.